earnings
confidence high
sentiment positive
materiality 0.70
iRadimed Q1 revenue $12.3M (+33% YoY), EPS $0.20; raises FY22 guidance
IRADIMED CORP
2022-Q1 EPS reported
$0.20
revenue$12,310,710
- Q1 revenue $12.3M vs $9.2M YoY; GAAP diluted EPS $0.20 vs $0.11; non-GAAP EPS $0.22 vs $0.13.
- Raised FY22 guidance: revenue $52.5-53.2M (prev $51.4-52.2M), GAAP EPS $0.89-0.95, non-GAAP EPS $0.96-1.03.
- Q2 guidance: revenue $12.5-12.7M, GAAP EPS $0.21-0.23, non-GAAP EPS $0.23-0.25.
- Paid special dividend of $1.00 per share during Q1 2022; monitors segment revenue surged to $5.19M from $2.60M YoY.